Trial Identifier: | D133HR00026 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05887011 |
Start Date: | March 2023 |
Primary Completion Date: | June 2026 |
Study Completion Date: | June 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Grozniy, Russia |
Russia | Irkutsk, Russia |
Russia | Kostroma, Russia |
Russia | Sochi, Russia |
Russia | Yuzhno-Sakhalinsk, Russia |